top of page

Bortizomib 3.5MG Injection

$141.00Price
Bortenat 3.5MG Injection
1 VIAL
2 VIAL
3 VIAL
4 VIAL

 Injection is used in the treatment of multiple myeloma and mantle-cell lymphoma. It shows its working by stopping or slowing down the growth of cancer cells.

About This Medicine

Short Description


Bortezomib 3.5mg injection is a chemotherapy medicine belonging to a class called proteasome inhibitors. It is used in the treatment of certain blood cancers, primarily multiple myeloma, and is administered under the supervision of a healthcare professional as part of a broader cancer treatment plan.


What Is Bortezomib 3.5mg?


Bortezomib 3.5mg is a powder solution for injection containing bortezomib as its active substance. It belongs to a class of anti-cancer medicines known as proteasome inhibitors.


This medicine works by interfering with processes inside cancer cells that help them grow and survive. It is used specifically for certain types of blood cancer and is always given by a trained healthcare professional in a clinical setting, not self-administered at home.


Uses


Bortezomib 3.5mg may be prescribed to:


  • Treat multiple myeloma, a cancer affecting plasma cells in the bone marrow

  • Treat mantle cell lymphoma in patients who have not responded to at least one previous treatment

  • Form part of a combination chemotherapy regimen alongside other cancer medicines, depending on the specific condition being treated


The appropriate treatment plan and dose for Bortezomib should be determined by an oncologist or haematologist based on the specific diagnosis and treatment history.


How Does Bortezomib Work?


Bortezomib works by blocking a cell structure called the proteasome, which normally breaks down proteins that cells no longer need. Cancer cells rely heavily on this process to keep growing and to avoid self-destruction.


By inhibiting the proteasome, Bortezomib disrupts this balance inside cancer cells, triggering processes that lead to their death while having a comparatively smaller effect on normal cells. Response to treatment is usually assessed over a period of weeks to months through regular blood tests and clinical monitoring, as part of a defined treatment cycle.


How to Take Bortezomib


Take Bortezomib exactly as prescribed by your healthcare professional.


  • Administered only by a doctor or nurse, either as an injection into a vein (intravenous) or under the skin (subcutaneous), never at home

  • Given according to a specific treatment cycle and schedule set by your oncology team, typically with rest days built in between doses

  • Often given alongside other supportive or anti-cancer medicines as part of a combination regimen

  • Regular blood tests are usually required before each dose to check that treatment can safely continue

  • Do not stop, delay, or change your treatment schedule without speaking to your oncology team, as dosing is closely tied to your individual response and blood counts


Because this medicine is administered by a healthcare professional according to a monitored schedule, missed-dose guidance does not apply in the way it would for a self-administered medicine; your treatment team will manage timing adjustments if needed.


Important Safety Information


Tell your doctor or pharmacist about your full medical history and all medicines, supplements, and herbal products you use before starting Bortezomib.


Caution or closer monitoring may be needed if you have:


  • A history of low blood cell counts (red cells, white cells, or platelets)

  • Numbness, tingling, or pain in the hands or feet (peripheral neuropathy), which may worsen with treatment

  • Heart or blood pressure problems, including a history of fainting or dizziness

  • Kidney or liver problems

  • A history of bowel problems such as constipation, diarrhea, or blockage


Bortezomib may interact with other medicines, particularly those affecting liver enzyme activity (such as certain antifungals or antiviral medicines), other chemotherapy agents, and medicines affecting blood pressure or blood clotting. This is not a complete list of possible interactions, so it's important to check with your doctor or pharmacist about any other medicines or supplements you are taking.


Pregnancy & Breastfeeding


The effects of Bortezomib on pregnancy are not well established, and it is generally not recommended for use during pregnancy due to its potential to affect cell growth and development. Effective contraception is generally advised for patients of childbearing potential during and after treatment, as recommendations may vary by country and clinical guidance.


Breastfeeding is generally not recommended during Bortezomib treatment, as it is not known whether the medicine passes into breast milk. Speak with your oncology team about pregnancy planning, contraception, and breastfeeding before and during treatment.


Side Effects


Like all medicines, Bortezomib can cause side effects, although not everyone experiences them.


Common side effects include:


  • Nausea, vomiting, diarrhea, or constipation

  • Fatigue and general weakness

  • Numbness, tingling, burning, or pain in the hands or feet

  • Low blood cell counts, which may increase the risk of infection, bruising, or bleeding

  • Fever

  • Redness or pain at the injection site


Seek prompt medical attention if you experience signs of a serious infection, unusual bleeding or bruising, severe or worsening numbness or weakness, shortness of breath or swelling of the legs, signs of liver problems (such as yellowing of the skin or eyes, dark urine), or a severe allergic reaction (such as swelling of the face or throat, or difficulty breathing).


This is not a complete list of side effects or warnings. Please refer to the product packaging and patient information leaflet supplied with your medicine for complete information and speak with your doctor or pharmacist if you have concerns.


Storage


Store Bortezomib according to the instructions shown on the original product packaging.


  • Keep in the original packaging until ready for use by a healthcare professional

  • Protect from light where indicated on the packaging

  • Keep out of reach and sight of children

  • Do not use after the expiry date shown on the packaging

Frequently Asked Questions


What is Bortezomib 3.5mg used for?

It is used mainly to treat multiple myeloma and, in some cases, mantle cell lymphoma, as part of a broader cancer treatment plan.


How is Bortezomib given?

It is given only by a healthcare professional, as an injection into a vein or under the skin, following a specific treatment cycle.


How long does Bortezomib take to work?

Response is typically assessed over several weeks to months through blood tests and clinical evaluation, and this can vary between patients.


Can Bortezomib be taken at home?

No. It is administered exclusively in a clinical setting by trained healthcare staff.


Is generic bortezomib the same as branded versions?

Generic bortezomib contains the same active substance and is expected to work the same way, though formulation details may differ between manufacturers.


Why do I need regular blood tests during treatment?

Blood counts are checked regularly to ensure treatment can continue safely and to guide any necessary dose adjustments.


Should treatment be stopped once symptoms improve?

No. Treatment duration and any changes to your regimen should be decided by your oncology team based on your overall response and blood test results.


bottom of page